Vir Biotechnology Inc (VIR)

Exchange
NASDAQ
Symbol
VIR
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Country
USA

Stock price

At close: November 20, 2024

  • Open
    6.86
  • High
    7.03
  • Low
    6.62
  • Close
    6.74
  • Volume
    1,473,680

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
—
Receivables turnover
—
Payables turnover
0.44
Working capital turnover
0.06
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
—
Number of days of payables
836.13
Fixed asset turnover
0.90
Total asset turnover
0.04
 Liquidity ratios
Current ratio
9.05
Quick ratio
9.29
Cash ratio
9.29
Cash conversion cycle
-836.13
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.21
Interest coverage
-1,431.60
 Profitability ratios
Gross profit margin
96.79%
Operating profit margin
-794.04%
Pretax margin
-728.93%
Net profit margin
-713.76%
Operating return on assets (Operating ROA)
-35.66%
Return on assets (ROA)
-32.05%
Return on total capital
-43.03%
Return on equity (ROE)
-38.68%